O TYM ODCINKU
Finding cancer earlier and learning more about its biology creates new possibilities for care. It also creates more work for the pathologists who examine samples, interpret results, and help guide treatment decisions. In this episode of Talking Precision Medicine, Rafael Rosengarten welcomes back Dr. Shakti Ramkissoon, senior vice president, enterprise oncology at Labcorp, to discuss the Pulse of the Pathologist report. Drawing on a survey of 148 practicing pathologists, they explore growing workloads, practical applications of AI, and what it takes to bring new diagnostic tools into everyday care.
TPM E63 highlights >
Episode 63 links:
Język angielski
Stany Zjednoczone
TRANSKRYPCJA 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki Talking Precision Medicine.
INNE ODCINKI W TYM PODCASCIE
Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon, VP of Oncology at Labcorp, to unpack the realities on the ground. From access gaps, reimbursement chall…
In this episode, Rafael Rosengarten speaks with Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer. Sean shares how pre-competitive collaboration across industry, academia, and regulators is helping address some of the biggest challenges in oncology. The conversation explores the role of data sha…
In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in …
In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotec…
In this episode, I’m joined by Colette Delawalla, founder and CEO of Stand Up For Science. What began as frustration over a federal “banned words” list evolved into a national mobilization effort to defend scientific freedom and evidence-based policymaking. We talk about the organization’s origin s…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Genialis, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
